These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2421831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release.
    Cass WA, Zahniser NR.
    J Neurochem; 1991 Jul; 57(1):147-52. PubMed ID: 1828829
    [Abstract] [Full Text] [Related]

  • 4. Functional differences between 4-aminopyridine and tetraethylammonium-sensitive potassium channels in myelinated axons.
    Kocsis JD, Eng DL, Gordon TR, Waxman SG.
    Neurosci Lett; 1987 Mar 31; 75(2):193-8. PubMed ID: 2437499
    [Abstract] [Full Text] [Related]

  • 5. Effects of stimulus frequency and potassium channel blockade on the secretion of vasopressin and oxytocin from the neurohypophysis.
    Bondy CA, Gainer H, Russell JT.
    Neuroendocrinology; 1987 Sep 31; 46(3):258-67. PubMed ID: 2443864
    [Abstract] [Full Text] [Related]

  • 6. Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation.
    Garcia-Munoz M, Young SJ, Groves PM.
    Brain Res; 1991 Jun 14; 551(1-2):195-206. PubMed ID: 1913151
    [Abstract] [Full Text] [Related]

  • 7. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow.
    Tepper JM, Young SJ, Groves PM.
    Brain Res; 1984 Sep 10; 309(2):309-16. PubMed ID: 6089959
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Haghdoost-Yazdi H, Piri H, Faraji A, Fraidouni N, Dargahi T, Mahmudi M, Alipour Heidari M.
    Neurol Res; 2016 Apr 10; 38(4):294-300. PubMed ID: 27098232
    [Abstract] [Full Text] [Related]

  • 9. Mammalian optic nerve fibers display two pharmacologically distinct potassium channels.
    Kocsis JD, Gordon TR, Waxman SG.
    Brain Res; 1986 Sep 24; 383(1-2):357-61. PubMed ID: 2429732
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the presence of two types of potassium channels in the rat optic nerve.
    Gordon TR, Kocsis JD, Waxman SG.
    Brain Res; 1988 Apr 26; 447(1):1-9. PubMed ID: 2454699
    [Abstract] [Full Text] [Related]

  • 11. Potassium channels moderate ectopic excitability of nerve-end neuromas in rats.
    Devor M.
    Neurosci Lett; 1983 Sep 30; 40(2):181-6. PubMed ID: 6314210
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of potassium channel blockers on dopamine release from rat striatal slices.
    Boireau A, Richard F, Olivier V, Aubeneau M, Miquet JM, Dubédat P, Laduron P, Doble A, Blanchard JC.
    J Pharm Pharmacol; 1991 Nov 30; 43(11):798-801. PubMed ID: 1686910
    [Abstract] [Full Text] [Related]

  • 13. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation.
    Gariano RF, Sawyer SF, Tepper JM, Young SJ, Groves PM.
    Brain Res Bull; 1989 Mar 30; 22(3):517-23. PubMed ID: 2713724
    [Abstract] [Full Text] [Related]

  • 14. Differential sensitivity of amphibian nodal and paranodal K+ channels to 4-aminopyridine and TEA.
    Schauf CL.
    Experientia; 1987 Apr 15; 43(4):405-8. PubMed ID: 2436941
    [Abstract] [Full Text] [Related]

  • 15. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Apr 15; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 16. Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibers.
    Eng DL, Gordon TR, Kocsis JD, Waxman SG.
    J Neurophysiol; 1988 Dec 15; 60(6):2168-79. PubMed ID: 2853208
    [Abstract] [Full Text] [Related]

  • 17. Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia.
    Kumamoto E, Kuba K.
    J Pharmacol Exp Ther; 1985 Oct 15; 235(1):241-7. PubMed ID: 2413197
    [Abstract] [Full Text] [Related]

  • 18. Effects of tetraethylammonium and 4-aminopyridine on the plateau potential of circular myometrium from the pregnant rat.
    Wilde DW, Marshall JM.
    Biol Reprod; 1988 May 15; 38(4):836-45. PubMed ID: 2456792
    [Abstract] [Full Text] [Related]

  • 19. On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals.
    Bitran M, Bustos G.
    Biochem Pharmacol; 1982 Sep 15; 31(18):2851-60. PubMed ID: 7138580
    [No Abstract] [Full Text] [Related]

  • 20. Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo.
    Trent F, Tepper JM.
    Exp Brain Res; 1991 Sep 15; 84(3):620-30. PubMed ID: 1830848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.